DPM Map for eba_tC_47.00

AddressLabelMetricsData TypePeriod Typeeba_dim:APReba_dim:BASeba_dim:CFOeba_dim:MCYeba_dim:OFSeba_dim:RPR
r0.010eba_a2.root/Amount / Ratio   N/AN/AN/AN/AN/AN/A
009.010Exposure Values/Amount / Ratio   N/AN/AN/AN/AN/AN/A
010.010SFTs: Exposure in accordance with Article 429 (5) and 429 (8) of the CRR/Amount / Ratioeba_met:mi265xbrli:monetaryItemTypeinstantN/Aeba_BA:x9N/Aeba_MC:x306N/AN/A
020.010SFTs: Add-on for counterparty credit risk/Amount / Ratioeba_met:mi425xbrli:monetaryItemTypeinstanteba_AP:x96eba_BA:x9N/Aeba_MC:x306N/Aeba_RP:x31
030.010Derogation for SFTs: Add-on in accordance with Article 429b (4) and 222 of the CRR/Amount / Ratioeba_met:mi426xbrli:monetaryItemTypeinstanteba_AP:x97eba_BA:x9N/Aeba_MC:x306N/AN/A
040.010Counterparty credit risk of SFT agent transactions in accordance with Article 429b (6) of the CRR/Amount / Ratioeba_met:mi425xbrli:monetaryItemTypeinstanteba_AP:x96eba_BA:x9N/Aeba_MC:x306N/Aeba_RP:x29
050.010(-) Exempted CCP leg of client-cleared SFT exposures/Amount / Ratioeba_met:mi427xbrli:monetaryItemTypeinstantN/Aeba_BA:x9N/Aeba_MC:x306N/Aeba_RP:x30
060.010Derivatives: Current replacement cost/Amount / Ratioeba_met:mi428xbrli:monetaryItemTypeinstanteba_AP:x106eba_BA:x9N/Aeba_MC:x99N/AN/A
070.010(-) Eligible cash variation margin received offset against derivatives market value/Amount / Ratioeba_met:mi429xbrli:monetaryItemTypeinstanteba_AP:x106eba_BA:x9N/Aeba_MC:x99N/AN/A
080.010(-) Exempted CCP leg of client-cleared trade exposures (replacement costs)/Amount / Ratioeba_met:mi427xbrli:monetaryItemTypeinstanteba_AP:x106eba_BA:x9N/Aeba_MC:x99N/Aeba_RP:x30
090.010Derivatives: Add-on under the mark-to-market method/Amount / Ratioeba_met:mi430xbrli:monetaryItemTypeinstanteba_AP:x102eba_BA:x9N/Aeba_MC:x99N/AN/A
100.010(-) Exempted CCP leg of client-cleared trade exposures (potential future exposure)/Amount / Ratioeba_met:mi427xbrli:monetaryItemTypeinstanteba_AP:x102eba_BA:x9N/Aeba_MC:x99N/Aeba_RP:x30
110.010Derogation for derivatives: original exposure method/Amount / Ratioeba_met:mi431xbrli:monetaryItemTypeinstanteba_AP:x107eba_BA:x9N/Aeba_MC:x99N/AN/A
120.010(-) Exempted CCP leg of client-cleared trade exposures (original exposure method)/Amount / Ratioeba_met:mi427xbrli:monetaryItemTypeinstanteba_AP:x107eba_BA:x9N/Aeba_MC:x99N/Aeba_RP:x30
130.010Capped notional amount of written credit derivatives/Amount / Ratioeba_met:mi419xbrli:monetaryItemTypeinstanteba_AP:x99eba_BA:x9N/Aeba_MC:x168N/AN/A
140.010(-) Eligible purchased credit derivatives offset against written credit derivatives/Amount / Ratioeba_met:mi432xbrli:monetaryItemTypeinstanteba_AP:x99eba_BA:x9N/Aeba_MC:x168N/AN/A
150.010Off-balance sheet items with a 10% CCF in accordance with Article 429 (10) of the CRR/Amount / Ratioeba_met:mi180xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_PC:x6eba_MC:x176N/AN/A
160.010Off-balance sheet items with a 20% CCF in accordance with Article 429 (10) of the CRR/Amount / Ratioeba_met:mi180xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_PC:x8eba_MC:x176N/AN/A
170.010Off-balance sheet items with a 50% CCF in accordance with Article 429 (10) of the CRR/Amount / Ratioeba_met:mi180xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_PC:x10eba_MC:x176N/AN/A
180.010Off-balance sheet items with a 100% CCF in accordance with Article 429 (10) of the CRR/Amount / Ratioeba_met:mi180xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_PC:x14eba_MC:x176N/AN/A
190.010Other assets/Amount / Ratioeba_met:mi265xbrli:monetaryItemTypeinstantN/Aeba_BA:x9N/Aeba_MC:x346N/AN/A
200.010Gross up for derivatives collateral provided/Amount / Ratioeba_met:mi265xbrli:monetaryItemTypeinstanteba_AP:x103eba_BA:x9N/Aeba_MC:x415N/AN/A
210.010(-) Receivables for cash variation margin provided in derivatives transactions/Amount / Ratioeba_met:mi265xbrli:monetaryItemTypeinstanteba_AP:x98eba_BA:x9N/Aeba_MC:x346N/AN/A
220.010(-) Exempted CCP leg of client-cleared trade exposures (initial margin)/Amount / Ratioeba_met:mi427xbrli:monetaryItemTypeinstantN/Aeba_BA:x9N/Aeba_MC:x346N/Aeba_RP:x30
230.010Adjustments for SFT sales accounting transactions/Amount / Ratioeba_met:mi265xbrli:monetaryItemTypeinstanteba_AP:x108eba_BA:x9N/Aeba_MC:x346N/AN/A
240.010(-) Fiduciary assets/Amount / Ratioeba_met:mi265xbrli:monetaryItemTypeinstanteba_AP:x101eba_BA:x9N/Aeba_MC:x346N/AN/A
250.010(-) Exemption of intragroup exposures (solo basis) in accordance with Article 429(7) of the CRR/Amount / Ratioeba_met:mi265xbrli:monetaryItemTypeinstanteba_AP:x101eba_BA:x9N/Aeba_MC:x625N/AN/A
260.010(-) Exposures exempted in accordance with Article 429 (14) of the CRR/Amount / Ratioeba_met:mi265xbrli:monetaryItemTypeinstanteba_AP:x100eba_BA:x9N/Aeba_MC:x625N/AN/A
270.010(-) Asset amount deducted - Tier 1 - fully phased-in definition/Amount / Ratioeba_met:mi423xbrli:monetaryItemTypeinstantN/Aeba_BA:x11N/Aeba_MC:x622eba_OF:x8N/A
280.010(-) Asset amount deducted - Tier 1 - transitional definition/Amount / Ratioeba_met:mi424xbrli:monetaryItemTypeinstantN/Aeba_BA:x11N/Aeba_MC:x622eba_OF:x8N/A
290.010Total Leverage Ratio exposure - using a fully phased-in definition of Tier 1 capital/Amount / Ratioeba_met:mi76xbrli:monetaryItemTypeinstantN/Aeba_BA:x9N/Aeba_MC:x623N/AN/A
300.010Total Leverage Ratio exposure - using a transitional definition of Tier 1 capital/Amount / Ratioeba_met:mi76xbrli:monetaryItemTypeinstantN/Aeba_BA:x9N/Aeba_MC:x624N/AN/A
309.010Capital/Amount / Ratio   N/Aeba_BA:x11N/Aeba_MC:x275eba_OF:x8N/A
310.010Tier 1 capital - fully phased-in definition/Amount / Ratioeba_met:mi58xbrli:monetaryItemTypeinstantN/Aeba_BA:x11N/Aeba_MC:x275eba_OF:x8N/A
320.010Tier 1 capital - transitional definition/Amount / Ratioeba_met:mi81xbrli:monetaryItemTypeinstantN/Aeba_BA:x11N/Aeba_MC:x275eba_OF:x8N/A
329.010Leverage Ratio/Amount / Ratio   N/Aeba_BA:x17N/Aeba_MC:x626N/AN/A
330.010Leverage Ratio - using a fully phased-in definition of Tier 1 capital/Amount / Ratioeba_met:pi270num:percentItemTypeinstantN/Aeba_BA:x17N/Aeba_MC:x626N/AN/A
340.010Leverage Ratio - using a transitional definition of Tier 1 capital/Amount / Ratioeba_met:pi271num:percentItemTypeinstantN/Aeba_BA:x17N/Aeba_MC:x626N/AN/A